×
OSR Holdings EBIT 2022-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OSR Holdings ebit from 2022 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
OSR Holdings EBIT 2022-2025 | OSRH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
OSR Holdings ebit from 2022 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.1B
CVS Health (CVS)
$76.8B
Elevance Health (ELV)
$65.1B
Cencora (COR)
$56.3B
DiDi Global (DIDIY)
$25.7B
Labcorp Holdings (LH)
$22.2B
Natera (NTRA)
$19B
BioMerieux (BMXMF)
$17.7B
EUROFINS SCIENT (ERFSF)
$15.9B
ICON (ICLR)
$15.1B
CochLear (CHEOY)
$13.4B
Solventum (SOLV)
$12.9B
Medpace Holdings (MEDP)
$12.6B
Revvity (RVTY)
$12.2B
Viatris (VTRS)
$11B
Avantor (AVTR)
$9.7B
Sonic Healthcare (SKHHY)
$9.1B
Charles River Laboratories (CRL)
$8.7B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$7.5B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5.1B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.5B
Surgery Partners (SGRY)
$2.7B
Organon (OGN)
$2.7B
Concentras Parent (CON)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
GeneDx Holdings (WGS)
$2.3B
Progyny (PGNY)
$2B